Examining the Evolving Landscape of Cancer Health Disparities Research
The AACR Conference on the Science of Cancer Health Disparities explored the field's evolving landscape, including funding and and long-term impact.
Progress Against Cancer
The AACR Conference on the Science of Cancer Health Disparities explored the field's evolving landscape, including funding and and long-term impact.
Frank McCormick, PhD, FAACR, reflected on a career chasing the notorious RAS oncogene that earned him the inaugural Stephenson Global Prize.
The psychological toll of cancer can have an impact on patients’ mental health and put them at an increased risk of harm.
Older people with multiple myeloma can receive a less toxic drug regimen, and the FDA approves an immunotherapy for people with high-risk skin cancer.
The FDA approved cemiplimab-rwlc as an adjuvant therapy for patients with cutaneous squamous cell carcinoma at high risk of recurrence. The U.S. Food and Drug Administration (FDA) has approved cemiplimab-rwlc (Libtayo) for use after...
Patients with cancer in rural or high-poverty areas were associated with the most significant improvements in five-year survival. In 2014, a provision under the Patient Protection and Affordable Care Act (ACA) took effect, allowing...
Widespread uptake of HPV vaccine linked to reduced rates of cancer-causing infection in all, and radiation prevents recurrence in locally advanced bladder cancer.
The FDA has approved the DNA-damaging agent in combination with immunotherapy for patients whose cancers have not progressed after first-line therapy. The U.S. Food and Drug Administration (FDA) has approved lurbinectedin (Zepzelca) in combination...
For September 2025, the editors of AACR's journals highlighted studies on cervical cancer screening, supercharging immunotherapy, and more.
US trial to look at impact of AI-assisted mammograms, and vitamin B12 may help curb chemotherapy-associated hand-foot syndrome.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More